The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer

Lung cancer is a common malignant cancer. Kirsten rat sarcoma oncogene (KRAS) mutations have been considered as a key driver for lung cancers. KRAS p.G12C mutations were most predominant in NSCLC which was comprised about 11–16% of lung adenocarcinomas (p.G12C accounts for 45–50% of mutant KRAS). Bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jisong, Hu, Huihui, Xu, Shan, Jiang, Hanliang, Zhu, Jihong, Qin, E., He, Zhengfu, Chen, Enguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010953/
https://www.ncbi.nlm.nih.gov/pubmed/32117436
http://dx.doi.org/10.3389/fgene.2020.00017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010953/
https://www.ncbi.nlm.nih.gov/pubmed/32117436
http://dx.doi.org/10.3389/fgene.2020.00017

Ejemplares similares